Request Deal Involvement

Arix Bioscience and 5AM Ventures led a $135m Series B round in Ensoma.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

1AB

pr advisors

1AB

or

Principals

ARIX BIOSCIENCE

bidder

ARIX BIOSCIENCE

5AM VENTURES LLC

bidder

5AM VENTURES LLC

VIKING GLOBAL INVESTORS

bidder

VIKING GLOBAL INVESTORS

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

MIRAE ASSET CAPITAL CO LTD

bidder

MIRAE ASSET CAPITAL CO LTD

BIOLUMINESCENCE VENTURES

bidder

BIOLUMINESCENCE VENTURES

DELOS CAPITAL

bidder

DELOS CAPITAL

F-PRIME CAPITAL

bidder

F-PRIME CAPITAL

SOLASTA VENTURES

bidder

SOLASTA VENTURES

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

FRED HUTCHINSON CANCER RESEARCH CENTER

bidder

FRED HUTCHINSON CANCER RESEARCH CENTER

QATAR INVESTMENT AUTHORITY

bidder

QATAR INVESTMENT AUTHORITY

CATALIO CAPITAL MANAGEMENT

bidder

CATALIO CAPITAL MANAGEMENT

ENSOMA

target

ENSOMA

TAKEDA VENTURES

bidder

TAKEDA VENTURES

SYMBIOSIS

bidder

SYMBIOSIS

BILL AND MELINDA GATES FOUNDATION

bidder

BILL AND MELINDA GATES FOUNDATION

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Arix Bioscience and 5AM Ventures led a $135m Series B round in Ensoma.